Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis

Journal of Hepatology

Volumn 37, Issue 4, 2002, Pages 456-462

  Chiva, Maite ^a   Soriano, Germán ^a   Rochat, Isabelle ^b   Peralta, Carmen ^a   Rochat, Florence ^b   Llovet, Teresa ^c   Mirelis, Beatriz ^c   Schiffrin, Eduardo J ^b   Guarner, Carlos ^a   Balanzó, Joaquim ^a  

^a Liver Section   (Spain)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Antioxidants; Bacterial translocation; Experimental cirrhosis; Lactobacillus johnsonii; Probiotics; Spontaneous bacterial peritonitis

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CARBON TETRACHLORIDE; GLUTAMIC ACID; MALONALDEHYDE; PROBIOTIC AGENT; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; BACTERIAL INFECTION; BACTERIAL TRANSLOCATION; CECUM; CONTROLLED STUDY; ENDOTOXEMIA; FEEDING; ILEUM; INTESTINE FLORA; LACTOBACILLUS JOHNSONII; LAPAROTOMY; LIVER CIRRHOSIS; MALE; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DISEASE MODEL; DRUG EFFECT; INTESTINE MUCOSA; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; OXIDATIVE STRESS; PERITONITIS; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; ASCITES; ASCORBIC ACID; BACTERIAL TRANSLOCATION; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; GLUTAMIC ACID; INTESTINAL MUCOSA; LACTOBACILLUS; LIVER CIRRHOSIS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PERITONITIS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036784421     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00142-3     Document Type: Article

References (47)

1. Llovet JM, Bartoli R, Planas R, Cabré E, Jiménez M, Urban A, et al. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 1994;35:1648-1652.
2. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994;21:792-796.
3. Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taurá P, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001;34:32-37.
4. García-Tsao G, Fa-Yauh L, Barden GE, Cartun R, West B. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995;108:1835-1841.
5. García-Tsao G. Bacterial translocation: cause or consequence of decompensation in cirrhosis? J Hepatol 2001;34:150-155.
6. Casafont F, de las Heras G, Martín L, López MJ, Ledesma F, Pons F. Small intestinal bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1995;40:1252-1256.
7. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997;26:1372-1378.
8. Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestinal dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998;28:1187-1190.
9. Pardo A, Bartoli R, Lorenzo-Zúñiga V, Planas R, Viñado B, Riba J, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000;31:858-863.
10. Pérez-Páramo M, Muñoz J, Albillos A, Freile I, Portero F, Santos M, et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000;31:43-48.
11. Bolognesi M, Merkel C, Bianco S, Angeli P, Sacerdoti D, Amodio P, et al. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 1994;19:628-634.
12. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocyticosis, intracellular killing, and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 1986;6:252-262.
13. Such J, Guarner C, Enríquez J, Rodríguez JL, Serés I, Vilardell F. Low C3 in ascitic fluid predisposes to spontaneous bacterial peritonitis. J Hepatol 1988;6:80-84.
14. Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999;11:755-759.
15. Runyon BA, Borzio M, Young S, Squier S, Guarner C, Runyon MA. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology 1995;21:1719-1724.
16. Guarner C, Runyon BA, Heck M, Young S, Sheikh MY. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats. Dig Dis Sci 1999;44:1957-1962.
17. Ginès P, Rimola A, Planas R. Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind placebo-controlled trial. Hepatology 1990;12:716-724.
18. Soriano G, Guarner C, Teixidó M, Such J, Barrio J, Enríquez J, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991;100:477-481.
19. Soriano G, Guarner C, Tomás A, Villanueva C, Torras X, González D, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992;103:1267-1272.
20. Novella MT, Solà R, Soriano G, Andreu M, Gana J, Ortiz J, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997;25:532-536.
21. Ortiz J, Vila MC, Soriano G, Miñana J, Gana J, Mirelis B, et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 1999;29:1064-1069.
22. Dupeyron C, Mangeney N, Sedrati L, Campillo B, Fouet P, Leluan G. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother 1994;38:340-344.
23. Campillo B, Dupeyron C, Richardet JP, Mangeney N, Leluan G. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis 1998;26:1066-1070.
24. Kaye KS, Fraimow HS, Abrutyn E. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am 2000;14:293-319.
25. Elmer GW, Surawicz ChM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. J Am Med Assoc 1996;275:870-876.
26. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J Am Med Assoc 1994;271:1913-1918.
27. Wang XD, Soltesz V, Molin G, Andersson R. The role of oral administration of oatmeal fermented by Lactobacillus reuteri R2LC on bacterial translocation after acute liver failure induced by subtotal liver resection in the rat. Scand J Gastroenterol 1995;30:180-185.
28. Adawi D, Kasravi FB, Molin G, Jeppsson B. Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology 1997;25:642-647.
29. Kasravi FB, Adawi D, Molin G, Bengmark S, Jeppsson B. Effect of oral supplementation of lactobacilli on bacterial translocation in acute liver injury induced by D-galactosamine. J Hepatol 1997;26:417-424.
30. Wiest R, Chen F, Cadelina G, García-Tsao G. Effect of Lactobacillus acidophilus-fermented diet on intestinal flora and on bacterial translocation in experimental pre-hepatic portal hypertension. Hepatology 1999;30:581A (abstract).
31. WHO Scientific Working Group on monitoring and management of bacterial resistance to antimicrobial agents, Geneva, 1994.
32. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interieukin 10 gene-deficient mice. Gastroenterology 1999;116:1107-1114.
33. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-497.
34. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992;32:141-144.
35. Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol 2000;95(Suppl):S16-S18.
36. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LC1 binds to cultured human intestinal cell lines and inhibits attachment and cell invasion by enterovirulent bacteria. Gut 1994;35:483-489.
37. Schimpl G, Pesendorfer P, Steinwender G, Feierl G, Ratschek M, Höllwarth ME. Allopurinol and glutamine attenuate bacterial translocation in chronic portal hypertensive and common bile duct ligated growing rats. Gut 1996;39:48-53.
38. Schimpl G, Pesendorfer P, Steinwender G, Feierl G, Ratsshek M, Höllwarth ME. The effect of vitamin C and vitamin E supplementation on bacterial translocation in chronic portal hypertensive and common-bile-duct-ligated rats. Eur Surg Res 1997;29:187-194.
39. Peralta C, Chiva M, Gómez C, Soriano G, Llovet T, Guarner C, et al. Portal hypertension, intestinal mucosal oxidative damage and bacterial translocation in an experimental model of cirrhosis. J Hepatol 2000;32(Suppl 2):146 (abstract).
40. Closa D, Bulbena O, Roselló-Catafau J, Fernández-Cruz L, Gelpí E. Effect of prostaglandins and superoxide dismutase administration on oxygen free radical production in experimental acute pancreatitis. Inflammation 1993;17:563-571.
41. Bielefeldt K, Conklin JL. Intestinal motility during hypoxia and reoxygenation in vitro. Dig Dis Sci 1997;42:878-884.
42. van der Vliet A, Tuinstra TJ, Bast A. Modulation of oxidative stress in the gastrointestinal tract and effect on rat intestinal motility. Biochem Pharmacol 1989;38:2807-2818.
43. Guarner C, Soriano G, Tomás A, Bulbena O, Novella MT, Balanzó J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993;18:1139-1143.
44. van Deventer SJH, Cate JW, Tytgat GNJ. Intestinal endotoxemia. Clinical significance. Gastroenterology 1988;94:825-831.
45. Unno N, Wang H, Menconi MJ, Tytgat SH, Larkin V, Smith M, et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997;113:1246-1257.
46. Kuratsune H, Koda T, Kurahori T. The relationship between endotoxin and the phagocytic activity of the reticuloendothelial system. Hepatogastroenterol 1983;30:79-82.
47. Caplan MS, Miller-Catchpole R, Kaup S, Russell T, Lickerman M, Amer M, et al. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 1999;117:577-583.